Solving the need for reliable biopsies

Biopsy technology aimed at removing the trade-off between patient safety and diagnostic accuracy

Get to know us

Lung cancer is the leading cause of cancer-related deaths, with less than one-third of patients expected to survive more than five years post-diagnosis

We develop advanced user-centered biopsy technology, which aims to allow for early and more accurate cancer diagnostics - the key for better treatment and patient care

“I noticed patients returning for a re-biopsy due to results being inconclusive.

They seemed exhausted and anxious, as the delays in diagnosis and the high risk of complications, such as collapsed lungs, weighed heavily.

I realized that many of these insufficiencies and complications could be solved with better equipment and training”

Inspired by Experience

Meet the MultiBiopsy team

William Ludvigsen COO of MultiBiopsy

Co-founder,
CEO, Engineer
LinkedIn

William Ludvigsen

Kristian Horsager

Co-founder,
CSO, Doctor
LinkedIn

Anton Esbjerg

Co-founder,
CPO, Engineer
LinkedIn

Caroline Jensen

Co-founder,
CTO, Engineer
LinkedIn

R&D Advisor
LinkedIn

Claus Baumann

Regulatory Advisor
LinkedIn

André Agerholm

Marianne Storgaard


Commercial & Team
Advisor
LinkedIn

Lucca Dürrfeld

Product Development Consultant
LinkedIn

Ignas Valavičius

Engineer Student
Assistant
LinkedIn

R&D, Engineer
LinkedIn

Victor Pedersen

Reach out or meet us at one of our locations

Copenhagen

At Republikken Create

Vesterbrogade 35A, st. tv,

1620 Copenhagen, Denmark

 

Universitetsbyen 76,

8000 Aarhus C, Denmark

Aarhus

 

MultiBiopsy

info@multibiopsy.com

LinkedIn.com

Send us a message!